YOLFTbeta
Scynexis Inc

Scynexis Inc

SCYX · NASDAQ · Healthcare / Drug Manufacturers - Specialty & Generic

3.21USD-0.12 (-3.60%)

Price History

Full chart

Market Stats

Previous Close3.33
Open3.35
Day Range3.10 – 3.35
52-Week Range3.53 – 9.12
Volume64.37K
Market Cap43.68M
P/E (TTM)0.00
Forward P/E1.85
EPS-0.91
Dividend Yield0.00%
Beta1.11
50-Day Avg4.76
200-Day Avg5.65

About

SCYNEXIS, Inc., a biotechnology company, engages in drug development for the treatment and prevention of difficult-to-treat and drug-resistant fungal infections in the United States. The company offers BREXAFEMME for the treatment of patients with vulvovaginal candidiasis and for the reduction in the incidence of recurrence. It also develops SCY-247, which is in Phase I clinical trial for the treatment of invasive fungal infections. The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEODr. David Gonzalez Angulo M.D.
  • Employees18
  • Headquarters1 Evertrust Plaza, Jersey City, NJ, United States, 07302-6548, USA
  • Websitehttps://www.scynexis.com

Leadership

  • Dr. David Gonzalez Angulo M.D.CEO, President & Director · b. 1965
  • Mr. Scott Sukenick J.D.Chief Legal Officer & Corporate Secretary · b. 1978
  • Ms. Daniella GiganteVice President of Human Resources & Information Technology

Financials

Income Statement

Currency: USD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue16.84M16.86M1.26M257.00K257.00K257.00K257.00K121.00K12.05M13.16M5.09M140.14M3.75M20.60M
Growth (%)-+0.12%-92.55%-79.54%0.00%0.00%0.00%-52.92%+9858.68%+9.24%-61.32%+2652.72%-97.33%+449.95%
Cost of Revenue14.36M16.30M15.45M28.55M28.05M26.54M0-303.00K312.00K628.00K15.62M0-
Gross Profit2.47M552.00K-14.19M257.00K257.00K257.00K257.00K121.00K-303.00K12.85M4.46M124.52M3.75M20.60M
Gross Margin14.69%3.27%-1129.78%100.00%100.00%100.00%100.00%100.00%-2.51%97.63%87.66%88.85%100.00%100.00%
Operating Expense10.26M7.76M457.00K28.61M28.07M26.58M30.24M49.04M50.85M73.69M90.22M51.85M40.86M36.67M
Operating Income-7.78M-7.20M-14.65M-28.35M-27.82M-26.32M-29.98M-48.92M-51.15M-60.84M-85.76M72.67M-37.12M-16.07M
Operating Margin-46.23%-42.74%-1166.16%-11030.74%-10823.74%-10241.25%-11666.54%-40430.58%-424.47%-462.19%-1684.48%51.85%-990.84%-78.03%
EBITDA-9.71M-13.76M-2.19M-27.90M-29.51M-23.16M-17.10M-51.27M-55.65M-32.91M-59.91M70.89M-18.58M-8.12M
EBITDA Margin-57.65%-81.63%-174.60%-10856.81%-11483.27%-9013.23%-6652.53%-42370.25%-461.81%-250.06%-1176.76%50.58%-496.08%-39.43%
Net Income-11.48M-30.46M-4.23M-32.62M-29.99M-25.06M-12.47M-53.71M-55.19M-32.87M-62.81M67.04M-21.29M-8.61M
Net Income Margin-68.17%-180.70%-337.10%-12693.77%-11668.87%-9750.97%-4851.36%-44388.43%-457.97%-249.68%-1233.73%47.84%-568.29%-41.79%
R&D8.93M4.36M8.29M16.44M20.08M18.33M21.56M38.39M36.52M23.77M27.26M30.93M26.41M22.28M
R&D as % of Total Revenue53.02%25.88%659.79%6396.89%7811.67%7130.74%8389.11%31730.58%303.09%180.60%535.44%22.07%704.89%108.15%
Interest Expense972.00K11.89M803.00K11.00K451.00K1.85M2.05M2.16M1.18M3.96M6.79M6.12M2.55M173.00K
Interest Expense % of Total Revenue5.77%70.51%63.93%4.28%175.49%721.79%799.22%1782.64%9.80%30.11%133.31%4.37%68.18%0.84%

Balance Sheet

Currency: USD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets12.12M12.44M39.67M49.27M59.79M45.85M53.17M57.15M102.54M119.84M87.81M128.41M90.64M59.03M
Total Liabilities31.45M21.14M6.24M7.32M24.97M24.44M21.95M44.26M79.78M78.58M84.58M55.45M35.57M9.65M
Total Equity-19.33M-8.70M33.43M41.95M34.82M21.41M31.23M12.89M22.76M41.26M3.23M72.96M55.08M49.38M
Cash2.38M1.45M32.24M46.98M35.66M11.47M11.44M41.92M93.04M104.48M45.81M34.05M16.05M21.26M
Total Debt26.44M15.00M--14.25M14.65M15.08M14.88M19.84M43.63M48.60M15.08M16.27M2.17M
Net Debt24.06M13.55M-32.24M-46.98M-21.40M3.18M3.64M-27.04M-73.20M-60.86M2.78M-18.97M219.00K-19.08M

Cash Flow

Currency: USD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-10.60M-4.31M-9.47M-24.55M-29.35M-24.56M-28.32M-38.12M-49.35M-54.56M-79.88M60.16M-24.01M-5.28M
Investing Cash Flow3.05M557.00K-488.00K1.59M-22.47M-9.62M-803.00K26.24M6.47M-1.17M-27.39M-34.88M6.15M24.31M
Financing Cash Flow5.95M2.77M40.80M37.70M40.50M9.99M29.42M42.30M94.00M67.12M48.60M-36.72M-139.00K-14.17M
Capital Expenditure361.00K431.00K704.00K589.00K27.00K2.00K565.00K4.00K4.00K1.17M9.00K60.16M00
Free Cash Flow-10.96M-4.74M-10.18M-25.13M-29.38M-24.56M-28.89M-38.12M-49.36M-55.73M-79.89M60.16M-24.01M-5.28M
Dividends Paid--0000--10.03M-----
FCF to OCF103.41%110.01%107.43%102.40%100.09%100.01%101.99%100.00%100.01%102.15%100.01%100.00%100.00%100.00%
Dividend Paid to FCF--0.00%0.00%0.00%0.00%---20.32%-----

Earnings

Report DateJun 16, 2014Aug 13, 2014Nov 13, 2014Mar 30, 2015May 15, 2015Aug 19, 2015Nov 13, 2015Mar 7, 2016May 9, 2016Aug 8, 2016Nov 7, 2016Mar 13, 2017May 8, 2017Aug 8, 2017Nov 7, 2017Mar 13, 2018May 8, 2018Aug 9, 2018Nov 13, 2018Mar 14, 2019May 8, 2019Aug 7, 2019Nov 12, 2019Mar 11, 2020May 11, 2020Aug 10, 2020Nov 6, 2020Mar 29, 2021May 17, 2021Aug 16, 2021Nov 10, 2021Mar 29, 2022May 12, 2022Aug 15, 2022Nov 9, 2022Mar 31, 2023May 10, 2023Aug 14, 2023Nov 13, 2023Feb 7, 2024May 8, 2024Aug 8, 2024Nov 6, 2024Mar 12, 2025May 15, 2025Aug 13, 2025Nov 5, 2025Mar 5, 2026May 11, 2026Aug 10, 2026Nov 4, 2026
EPS Estimate--32.00-42.00-7.10-31.20-40.00-49.87-5.67-49.60-40.60-37.33-3.77-22.40-22.40-24.00-2.85-15.20-14.06-13.60-1.42-15.31-15.60-18.08-1.90-12.00-9.52-8.56-0.81-5.55-4.72-5.64-0.77-6.20-4.72-3.94-3.25-0.2811.62-1.17-0.20-1.55-1.62-0.78-0.22-0.23-1.52-0.211.01-0.99-0.40-0.40
EPS Actual-525.91-63.27-36.00-4.50-60.00-42.40-43.20-5.90-41.60-44.80-22.74-0.50-20.00-12.80-24.80-2.70-9.60-18.40-11.19-1.00-35.84-12.27-11.20-2.20-5.60-4.24-9.12-3.53-0.600.48-5.56-1.05-1.36-2.48-4.96-2.32-0.7119.68-0.32-0.390.08-2.40-0.48-0.09-0.17-1.12-0.172.00-3.36-0.32-
Surprise--97.72%14.29%36.62%-92.31%-6.00%13.37%-4.06%16.13%-10.34%39.08%86.74%10.71%42.86%-3.33%5.26%36.84%-30.87%17.72%29.58%-134.10%21.35%38.05%-15.79%53.33%55.46%-6.54%-335.80%89.19%110.17%1.42%-36.36%78.06%47.46%-25.89%28.62%-153.57%69.36%72.65%-95.00%105.16%-48.15%38.46%59.09%26.09%26.32%19.05%97.37%-239.39%20.00%-
Timing-Pre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap43.68M
Enterprise Value-6.72M
Trailing P/E0.00
Forward P/E1.85
PEG Ratio0.00
Price / Sales2.27
Price / Book0.68
EPS-0.91
Book Value6.73
Revenue (TTM)19.22M
Gross Profit (TTM)19.22M
EBITDA-36.54M
Profit Margin-53.26%
Operating Margin-3308.51%
Return on Equity-18.38%
Return on Assets-20.82%
Shares Outstanding9.95M
Shares Float7.36M
Beta1.11
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 3 analystsTarget 36.55
  • Strong Buy
    2
  • Buy
    1

Ownership Breakdown

Institutions
62.10%
Insiders
1.99%
Retail / Other
35.91%

Top Institutional Holders

  • Great Point Partners LLC
    944.29K9.49%
  • Squadron Capital Management LLC
    756.88K7.61%
  • Propel Bio Management LLC
    543.48K5.46%
  • Adage Capital Partners Gp LLC
    543.48K5.46%
  • Heights Capital Management Inc
    2.09M2.62%
  • Avidity Partners Management LP
    260.21K2.62%
  • Kingdon Capital Management LLC
    247.81K2.49%
  • Vanguard Capital Management, LLC
    1.56M1.97%
  • Millennium Management LLC
    180.79K1.82%
  • Dafna Capital Management LLC
    135.87K1.37%
  • Empery Asset Management, LP
    126.45K1.27%
  • Acadian Asset Management LLC
    731.95K0.92%
  • Geode Capital Management, LLC
    486.37K0.61%
  • BlackRock Inc
    332.19K0.42%
  • Vanguard Fiduciary Trust Co
    225.74K0.28%
  • Renaissance Technologies Corp
    224.64K0.28%
  • Yakira Capital Management, Inc.
    188.60K0.24%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    291.29K2.93%
  • Fidelity Extended Market Index
    52.12K0.52%
  • Fidelity Series Total Market Index
    15.76K0.16%

Stock Splits

  • Jun 1, 20261:8
  • Jul 17, 20201:10